Free Trial

15 Healthcare Stocks that Analysts Love in a Post-Pandemic World - 1 of 15

 
 

Lonza Group (OTCMKTS:LZAGY)

Consensus Rating
Strong Buy
Rating Score
3.8
Ratings Breakdown
4 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
N/A

About Lonza Group

Lonza Group logoLonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Biologics, Small Molecules, Cell & Gene, and Capsules & Health Ingredients segments. Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
11/27/2024Redburn AtlanticUpgradeStrong-Buy
10/9/2024The Goldman Sachs GroupUpgradeStrong-Buy
6/23/2024Berenberg BankUpgradeStrong-Buy
2/2/2024Deutsche Bank AktiengesellschaftUpgradeHold ➝ Buy
10/9/2023BarclaysInitiated CoverageOverweight
7/14/2023HSBCInitiated CoverageBuy
5/17/2023Stifel NicolausInitiated CoverageHold
2/10/2023William BlairReiterated RatingOutperform
12/7/2022Credit Suisse GroupLower Price TargetOutperform ➝ OutperformCHF 700 ➝ CHF 580
10/4/2022Sanford C. BernsteinInitiated CoverageOutperform
 

Could This Tiny Device Help You Make an Extra $30k a Year? (Ad)

I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more than $9 trillion. That’s nearly 10 times more money than the market caps of Tesla… SpaceX… PayPal… Neuralink… and X… COMBINED.

Click here to see the details because I believe a lot of people will get rich.